Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Tomoyo Shinkawa"'
Autor:
Terufumi Kubo, Taro Sugawara, Tomoyo Shinkawa, Tomoyo Kurisu, Nodoka Kouzen, Toshiaki Tanaka, Fumimasa Fukuta, Kouji Yamasaki, Shintaro Sugita, Kazuhiko Matsuo, Rena Morita, Yoshihiko Hirohashi, Tomohide Tsukahara, Takayuki Kanaseki, Tadashi Hasegawa, Naoya Masumori, Toshihiko Torigoe
Publikováno v:
Immunological Medicine, Vol 44, Iss 2, Pp 136-141 (2021)
Effective management of immune-related adverse events in patients receiving immunotherapy for cancer is problematic. In this report, we present the case of a 58-year-old man with advanced clear cell renal cell carcinoma who responded well to a combin
Externí odkaz:
https://doaj.org/article/df76912d07174c658434da11e8f06dbd
Autor:
Terufumi Kubo, Tomoyo Shinkawa, Yasuhiro Kikuchi, Kenji Murata, Takayuki Kanaseki, Tomohide Tsukahara, Yoshihiko Hirohashi, Toshihiko Torigoe
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Extensive research over 100 years has demonstrated that tumors can be eliminated by the autologous immune system. Without doubt, immunotherapy is now a standard treatment along with surgery, chemotherapy, and radiotherapy; however, the field of cance
Externí odkaz:
https://doaj.org/article/c1ba13585a24451e961ca06f3bc499a5
Autor:
Tomoyo Shinkawa, Serina Tokita, Munehide Nakatsugawa, Yasuhiro Kikuchi, Takayuki Kanaseki, Toshihiko Torigoe
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
CD8+ T cells are capable of recognizing mutation-derived neoantigens displayed by HLA class I molecules, thereby exhibiting the ability to distinguish between cancer and normal cells. However, accumulating evidence has shown that only a small fractio
Externí odkaz:
https://doaj.org/article/cd207c8fc7084b698ed44490a7e0fda9
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/3a6765bd55f74e8093d9b496fcdcf6e0
Autor:
Terufumi Kubo, Yoshihiko Hirohashi, Hiromi Fujita, Shintaro Sugita, Yasuhiro Kikuchi, Tomoyo Shinkawa, Munehide Nakatsugawa, Mitsuhiro Tsujiwaki, Yuta Sudo, Yuichiro Asai, Yasuaki Umeda, Hiroki Takahashi, Tadashi Hasegawa, Toshihiko Torigoe
Publikováno v:
Respiratory Medicine Case Reports, Vol 25, Iss , Pp 306-308 (2018)
We present a case of ovarian clear-cell carcinoma that was initially diagnosed as adenocarcinoma of lung origin. This is an instructive diagnostic pitfall for clinicians and pathologists because of the unusual clinical course, small biopsy material,
Externí odkaz:
https://doaj.org/article/df2670a1366148249ba446cbca3688c8
Autor:
Toshihiko Torigoe, Takayuki Kanaseki, Noriyuki Sato, Ichiro Takemasa, Fumitake Hata, Tomohide Tsukahara, Yoshihiko Hirohashi, Tomoyo Shinkawa, Munehide Nakatsugawa, Vitaly Kochin, Tomomi Hirama, Serina Tokita, Yasuhiro Kikuchi
Table S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ccdaed12295ce466b1102fd51e7a84d
https://doi.org/10.1158/2326-6066.22544094
https://doi.org/10.1158/2326-6066.22544094
Autor:
Toshihiko Torigoe, Takayuki Kanaseki, Noriyuki Sato, Ichiro Takemasa, Fumitake Hata, Tomohide Tsukahara, Yoshihiko Hirohashi, Tomoyo Shinkawa, Munehide Nakatsugawa, Vitaly Kochin, Tomomi Hirama, Serina Tokita, Yasuhiro Kikuchi
CD8+ T cells recognize peptides displayed by HLA class I molecules on cell surfaces, monitoring pathologic conditions such as cancer. Advances in proteogenomic analysis of HLA ligandomes have demonstrated that cells present a subset of cryptic peptid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b162af571899da770a8b563bcbbcd4d
https://doi.org/10.1158/2326-6066.c.6550524.v1
https://doi.org/10.1158/2326-6066.c.6550524.v1
Autor:
Toshihiko Torigoe, Takayuki Kanaseki, Noriyuki Sato, Ichiro Takemasa, Fumitake Hata, Tomohide Tsukahara, Yoshihiko Hirohashi, Tomoyo Shinkawa, Munehide Nakatsugawa, Vitaly Kochin, Tomomi Hirama, Serina Tokita, Yasuhiro Kikuchi
Supplementary Information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::172d19293afe49c068f2b8463a417c6c
https://doi.org/10.1158/2326-6066.22544106.v1
https://doi.org/10.1158/2326-6066.22544106.v1
Autor:
Toshihiko Torigoe, Takayuki Kanaseki, Noriyuki Sato, Ichiro Takemasa, Fumitake Hata, Tomohide Tsukahara, Yoshihiko Hirohashi, Tomoyo Shinkawa, Munehide Nakatsugawa, Vitaly Kochin, Tomomi Hirama, Serina Tokita, Yasuhiro Kikuchi
Figures S1-S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d517a6de352396f90c60b18c3f11d95
https://doi.org/10.1158/2326-6066.22544112
https://doi.org/10.1158/2326-6066.22544112
Autor:
Yasuhiro Kikuchi, Tomomi Hirama, Serina Tokita, Fumitake Hata, Toshihiko Torigoe, Yoshihiko Hirohashi, Ichiro Takemasa, Tomohide Tsukahara, Noriyuki Sato, Tomoyo Shinkawa, Vitaly Kochin, Takayuki Kanaseki, Munehide Nakatsugawa
Publikováno v:
Cancer Immunology Research. 9:1342-1353
CD8+ T cells recognize peptides displayed by HLA class I molecules on cell surfaces, monitoring pathologic conditions such as cancer. Advances in proteogenomic analysis of HLA ligandomes have demonstrated that cells present a subset of cryptic peptid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85e23151802d9f4aef89a43a85a1fde9
https://doi.org/10.1158/2326-6066.cir-20-0964
https://doi.org/10.1158/2326-6066.cir-20-0964